NEURAXION LABS PRIVATE LIMITED

In their own words

NeuraXion Labs is driven by the mission to harness Artificial Intelligence and Deep Technology to democratize access to high-quality healthcare for everyone. By advancing the integration of AI in medical diagnostics, NeuraXion Labs is shaping the future of global health and ensuring equitable access to life-saving innovations worldwide. Innovation at core, NeuraXion Labs is AI born and developed a patented, next-generation AI solution, TumorXpert™, which uses a hybrid neuro-symbolic architecture that combines deep neural networks for pattern recognition with symbolic AI for logic-driven reasoning and knowledge-graph inference. This approach enables highly accurate, explainable interpretation of complex medical imaging, delivering reliable tumor detection that outperforms leading global AI imaging solutions in clinical evaluation. TumorXpert™ has been patented, cited, and published in high-impact international journals, underscoring its scientific novelty and differentiation. Value Proposition and Impact Clinical Impact: TumorXpert’s high diagnostic precision enables faster, more targeted interventions, increasing survival rates and reducing long-term neurological impairment in patients. NeuroTumorXpert™ is designed as a scalable foundation model, creating a unified, extensible AI layer for oncology diagnostics, extending beyond a single indication to power a full-stack AI diagnostic suite across diverse tumor and cancer types - brain, lung, breast, skin, gastrointestinal, throat, and other cancers. Operational Efficiency: Automated triaging reduces the workload on specialized radiologists, empowering primary care and district health centers to handle advanced diagnosis, thus mitigating staff shortages and urban-rural disparities. Economic Value: Early, accurate diagnosis reduces repeat imaging, misdiagnosis costs, and late-stage treatment expenses.

Written by the company on its public Startup India profile. Not verified by us.